Purinergic Signal
Purinergic Signalling
1573-9538
1573-9546
Springer Netherlands
Dordrecht


2072915
18404447
9068
10.1007/s11302-007-9068-9
Original Paper


New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile

Lambertucci
Catia

1

Cristalli
Gloria

1

Dal Ben
Diego

1

Kachare
Dhuldeo D.

1

Bolcato
Chiara

2

Klotz
Karl-Norbert

3

Spalluto
Giampiero

+39-040-5583726
+39-040-52572
spalluto@units.it

2
4

Volpini
Rosaria

+39-0737-402278
+39-0737-402295
rosaria.volpini@unicam.it

1
5

1
Department of Chemical Sciences, University of Camerino, 62032 Camerino, Italy 
2
Department of Pharmaceutical Sciences, University of Trieste, 34127 Trieste, Italy 
3
Institut für Pharmakologie und Toxikologie, Universität Würzburg, 97078 Würzburg, Germany 
4
Dipartimento di Scienze Farmaceutiche, p.le Europa, 1, 34127 Trieste, Italy 
5
Dipartimento di Scienze Chimiche, via S. Agostino, 1, 62032 Camerino, Italy 

19
9
2007

9
2007

3
4
339
346
20
7
2007

31
7
2007


© Springer Science + Business Media B.V. 2007

5–14
1
2A
3
2B
N
6
1
3
N
6
2A
2B
 subtype, adenine is a useful template for further development of simplified adenosine receptor antagonists with distinct receptor selectivity profiles.

Keywords
Adenine derivatives
Adenosine receptors
Adenosine receptor antagonists
Adenosine receptor ligands
G protein-coupled receptors

issue-copyright-statement
© Springer Science+Business Media B.V. 2007




Introduction
1
2
1
2A
2B
3
3
1
3
2A
2B
4
].
2B
5
6
5
7
8
9
2B
10
11
2B
10
12
1
2A
3
2B
13
2B
1
1
2
1
14
15
3
2B
3
16
4
2B
3,
17
1
Fig. 1
i
2B
 adenosine receptor antagonists




1
3
1
3
).
18
22
2B
2B
21
].
3
N
6
2B
 adenosine receptor subtypes.
N
6
5
6
7
14
2B
2
Fig. 2
Structures of designed compounds





Chemistry
5–14
1
2
5
23
15
5
5a
5
5a
1
2
5a
2
2
5
2
Scheme 1
a
b
2
3
3
, sealed tube, RT



Scheme 2
Reagents: i: CDI, dry THF, reflux




6
16
5
17
17a
24
1
17
17a
3
24
1
17
6
24
1
).
7–14
5
6
18–22
25
2
).

Results and discussion
1
2A
3
2B
3
N
6
1
3
N
2A
3
2B
i
50
i
26
1
Table 1
5–14



a
3
1
b
3
2A
c
i
2B
d
3
3
 receptors expressed in CHO cells.



5–14
1
2A
3
2B
i
N
6
5
6
7–14
1
2B
N
6
6
i
2B
 = 11 μM.
N
6
N
6
6
1
2A
3
2B
5
.
N
6
8
7
).
1
2B
3
N
6
1
3
2B
9
i
1
i
2B
i
3
10
i
1
i
2B
i
3
12
i
1
i
2B
i
3
13
i
1
i
2B
i
3
 = 19 μM).
2A
2A
5
7
9
12
6
8
10
13
N
6
2A
6
i
2A
N
6
2A
27
32
].
N
6
1
3
9
i
1
11
i
3
5
i
1
i
3
 > 100 μM).
9
11
para
1
3
12
14
) did not positively influence the binding profile.

Conclusions
2B
 adenosine receptor antagonists, increased knowledge of the structure-activity relationships in adenine derivatives.
N
6
1
3
2A
2B
1
3
 adenosine receptor antagonists.

Experimental section
Chemistry
General:
1
J
2
O. Thin layer chromatography (TLC) was carried out on precoated TLC plates with silica gel 60 F-254 (Merck). For column chromatography, silica gel 60 (Merck) was used. Elemental analyses were determined on Fisons Instruments Model EA 1108 CHNS-O model analyser and are within ± 0.4% of theoretical values.
5

and 7-propyladenine
5a

)
15
2
3
3
5
23
5a
3
OH.
5
1
d
6
J
3
CH
2

3
J
2
2
5
5
5
 (177.2) C, 54.22; H, 6.26; N, 39.52; found: C, 54.54; H, 6.71; N, 39.33.
5a
1
d
6
J
3
CH
2

3
J
2
2
5
5
5
 (177.2) C, 54.22; H, 6.26; N, 39.52; found: C, 54.45; H, 6.45; N, 39.45.

17

and 2,6-dichloro-7-propyl-9H-purine
17a

)
16
2
3
6
12
17
17a
24
].
17
1
d
6
J
2
CH
3

CH
2

3
J
2
8
8
2
4
 (231.1) C, 41.58; H, 3.49; N, 24.25. Found: C, 41.85; H, 3.70; N, 24.10.
17a
1
d
6
J
2
CH
3

CH
2

3
J
2
8
8
2
4
 (231.1) C, 41.58; H, 3.49; N, 24.25. Found: C, 41.75; H, 3.55; N, 24.19.

6

)
17
3
6
24
1
d
6

J
2
CH
3

CH
2

3
J
2
2
8
10
5
 (211.7) C, 45.40; H, 4.76; N, 33.09. Found: C, 45.75; H, 4.80; N, 32.87.

N
6
7

14

)
18–22
5
6
7–14
.

7

)
3
1
d
6
J
2
CH
3

CH
2

3
2
J
2
J
J
16
16
5
O (374.2) C, 51.35; H, 4.31; N, 18.71. Found: C, 51.65; H, 4.80; N, 18.50.

8

)
3
6
12
1
d
6
J
2
CH
3

CH
2

3
2
J
2
J
J
16
15
5
O (408.7) C, 47.02; H, 3.70; N, 17.14. Found: C, 47.49; H, 3.83; N, 17.40.

9

)
3
1
d
6
J
2
CH
3

CH
2

3
2
J
2
2
J
J
J
J
23
22
5
2
 (480.4) C, 57.51; H, 4.62; N, 14.58. Found: C, 57.99; H, 4.66; N, 14.55.

10

)
3
6
12
1
d
6
J
2
CH
3

CH
2

3
2
J
2
2
J
J
J
J
23
21
5
2
 (514.8) C, 53.66; H, 4.11; N, 13.60. Found: C, 53.75; H, 4.25; N, 13.29.

11

)
3
6
12
1
d
6
J
2
CH
3

CH
2

3
CH
3

2
J
2
2
J
24
25
5
2
 (415.5) C, 69.38; H, 6.06; N, 16.86. Found: C, 69.74; H, 6.35; N, 16.54.

12

)
3
1
d
6
J
2
CH
3

CH
2

3
2
J
2
2
J
J
23
23
5
2
 (401.5) C, 68.81; H, 5.77; N, 17.44. Found: C, 68.97; H, 5.89; N, 17.35.

13

)
3
1
d
6
J
2
CH
3

CH
2

3
2
J
2
2
J
J
23
22
5
2
 (435.9) C, 63.37; H, 5.09; N, 16.07. Found: C, 63.56; H, 5.14; N, 15.76.

14

)
3
1
d
6
J
2
CH
3

CH
2

3
3
2
J
2
2
J
J
J
J
24
24
5
3
 (465.9) C, 61.87; H, 5.19; N, 15.03. Found: C, 61.99; H, 5.33; N, 14.91.


Biology
26
g
g
. The membrane pellet was resuspended in the buffer used for the respective binding experiments, frozen in liquid nitrogen and stored at −80°C. For the measurement of adenylyl cyclase activity only one high speed centrifugation of the homogenate was used. The resulting crude membrane pellet was resuspended in 50 mM Tris/HCl, pH 7.4 and immediately used for the cyclase assay.
1
3
3
2A
3
3
3
i
33
2B
50
i
34
].



Acknowledgements
The expert technical assistance of Ms. Sonja Kachler is gratefully acknowledged. This work was supported by Fondo di Ricerca di Ateneo (University of Camerino) and by grants from the Italian Ministry of Research: FIRB 2003, and PRIN 2005.

References
1.
Cristalli G, Volpini R (eds) (2003) Adenosine receptors: medicinal chemistry, pharmacology and therapeutic applications. Curr Top Med Chem 3:355–469

2.
Robeva
AS

Woodard
RL

Ji
XD

Gao
Z

Bhattacharya
S

Taylor
HE

Rosin
DL

Linden
J


Molecular characterization of recombinant human adenosine receptors
Drug Dev Res
1996
39
243
252
10.1002/(SICI)1098-2299(199611/12)39:3/4<243::AID-DDR3>3.0.CO;2-R

Robeva AS, Woodard RL, Ji XD, Gao Z, Bhattacharya S, Taylor HE, Rosin DL, Linden J (1996) Molecular characterization of recombinant human adenosine receptors. Drug Dev Res 39:243–252 

3.
Fredholm
BB

IJzerman
AP

Klotz
K-N

Linden
J


International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors
Pharmacol Rev
2001
53
527
533

11734617


4.
Jacobson
MJ


Adenosine receptor agonists
Expert Opin Ther Pat
2002
12
489
501
10.1517/13543776.12.4.489

Jacobson MJ (2002) Adenosine receptor agonists. Expert Opin Ther Pat 12:489–501 

5.
Feoktistov
I

Biaggioni
I


2B
 receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma
J Clin Invest
1995
96
1979
1986

7560091


6.
Marquardt
DL

Walker
LL

Heinemann
S


Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells
J Immunol
1994
152
4508
4515

8157966


7.
Boyle
DL

Sajjadi
FG

Firestein
GS


Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation
Arthritis Rheum
1996
39
923
930
10.1002/art.1780390608

8651985


8.
Fiebich
BL

Biber
K

Guipko
K

Berger
M

Bauer
J

Calker
D


2B
 receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells
J Neurochem
1996
66
1426
1431

8627294


9.
Dubey
RK

Gillaspie
DG

Osaka
K

Suzuki
F

Jackson
EK


2B
 receptors
Hypertension
1996
27
786
793

8613241


10.
Feoktistov
I

Biaggioni
I


2B
 receptors
Pharmacol Rev
1997
49
381
402

9443164


11.
Feoktistov
I

Wells
JN

Biaggioni
I


2B
 receptors as therapeutic targets
Drug Dev Res
1998
45
198
206
10.1002/(SICI)1098-2299(199811/12)45:3/4<198::AID-DDR17>3.0.CO;2-#

Feoktistov I, Wells JN, Biaggioni I (1998) Adenosine A2B receptors as therapeutic targets. Drug Dev Res 45:198–206 

12.
Feoktistov
I

Biaggioni
I


2B
 receptors
Biochem Pharmacol
1998
55
627
633
10.1016/S0006-2952(97)00512-1

9515573


13.
Beukers
MW

Meurs
I

IJzerman
AP


2B
 receptor ligands
Med Res Rev
2006
26
667
698
10.1002/med.20069

16847822


14.
Kim
YC

Ji
X-D

Melman
N

Linden
J

Jacobson
KA


2B
 adenosine receptors
J Med Chem
2000
43
1165
1172
10.1021/jm990421v

10737749


15.
Kalla
RV

Elzein
E

Perry
T

Li
X

Palle
V

Varkhedkar
V

Gimbeò
A

Maa
T

Zang
D

Zablocki
J


2B
 adenosine receptor antagonists
J Med Chem
2006
49
3682
3692
10.1021/jm051268+

16759111


16.
Pastorin
G

Ros
T

Spalluto
G

Deflorian
F

Moro
S

Cacciari
B

Baraldi
PG

Gessi
S

Varani
K

Borea
PA


3
2B
 adenosine receptor subtypes: a molecular modeling investigation
J Med Chem
2003
46
4287
4296
10.1021/jm030852k

13678407


17.
Vidal
B

Nueda
A

Esteve
C

Domenech
T

Benito
S

Renoso
RF

Pont
M

Calbet
M

Lopez
R

Cadavid
MI

Loza
MI

Cardenas
A

Godessart
N

Beleta
J

Warzelow
G

Ryder
H


2B
 adenosine receptor antagonist
J Med Chem
2007
50
2732
2736
10.1021/jm061333v

17469811


18.
Cristalli
G

Camaioni
E

Costanzi
S

Vittori
S

Volpini
R

Klotz
KN


Characterization of potent ligands at human recombinant adenosine receptors
Drug Dev Res
1998
45
176
181
10.1002/(SICI)1098-2299(199811/12)45:3/4<176::AID-DDR14>3.0.CO;2-G

Cristalli G, Camaioni E, Costanzi S, Vittori S, Volpini R, Klotz KN (1998) Characterization of potent ligands at human recombinant adenosine receptors. Drug Dev Res 45:176–181 

19.
Camaioni
E

Costanzi
S

Vittori
S

Volpini
R

Klotz
KN

Cristalli
G


New substituted 9-alkylpurines as adenosine receptor ligands
Bioorg Med Chem
1998
6
523
533
10.1016/S0968-0896(98)00007-8

9629466


20.
Klotz
KN

Kachler
S

Lambertucci
C

Vittori
S

Volpini
R

Cristalli
G


9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities
Naunyn Schmiedebergs Arch Pharmacol
2003
367
629
634
10.1007/s00210-003-0749-9

12734636


21.
Volpini
R

Costanzi
S

Vittori
S

Cristalli
G

Klotz
K-N


2B
 adenosine receptors
Curr Top Med Chem
2003
3
427
443
10.2174/1568026033392264

12570760


22.
Volpini
R

Costanzi
S

Lambertucci
C

Vittori
S

Martini
C

Trincavelli
ML

Klotz
K-N

Cristalli
G


2- And 8-alkynyl-9-ethyladenines: synthesis and biological activity at human and rat adenosine receptors
Purinergic Signalling
2005
1
173
181
10.1007/s11302-005-6216-y

Volpini R, Costanzi S, Lambertucci C, Vittori S, Martini C, Trincavelli ML, Klotz K-N, Cristalli G (2005) 2- And 8-alkynyl-9-ethyladenines: synthesis and biological activity at human and rat adenosine receptors. Purinergic Signalling 1:173–181 

23.
Zhang
L

Fan
J

Vu
K

Hong
K

Brazidec
JY

Shi
J

Biamonte
M

Busch
DJ

Lough
RE

Grecko
R

Ran
Y

Sensintaffar
JL

Camal
A

Lundgren
K

Burrows
FJ

Mansfield
R

Timony
GA

Ulm
EH

Kasibhatla
SR

Boehm
M


7’-Substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors
J Med Chem
2006
49
5352
5362
10.1021/jm051146h

16913725


24.
Maruyama
T

Kozai
S

Sasaki
F


Methods for the synthesis of uric acid derivatives
Nucleosides Nucleotides Nucleic Acids
1998
19
1193
1203

10999257


25.
Karaneswsky C, Thomson D, Michellys A, Ruppar P, Chen JH (2005) Preparation of benzoic acid phenylacetic derivatives as HNT−4° modulators. PCT Int. Appl. WO2005009104200-40716

26.
Klotz
KN

Hessling
J

Hegler
J

Owman
C

Kull
B

Fredholm
BB

Lohse
MJ


Comparative pharmacology of human adenosine receptor subtypes—characterization of stably transfected receptors in CHO cells
Naunyn Schmiedebergs Arch Pharmacol
1998
357
1
9
10.1007/PL00005131

9459566


27.
Baraldi
PG

Cacciari
B

Pineda de las Infantas
MJ

Romagnoli
R

Spalluto
G

Volpini
R

Costanzi
S

Vittori
S

Cristalli
G

Melman
N

Park
K

Jacobson
KA


N
6

N
6

N
6

3
 adenosine receptor agonists
J Med Chem
1998
41
3174
3185
10.1021/jm980147p

9703463


28.
Volpini
R

Camaioni
E

Costanzi
S

Vittori
S

Klotz
K-N

Cristalli
G


Synthesis of di- and tri-substituted adenosine derivatives and their affinities at human adenosine receptor subtypes
Nucleosides Nucleotides
1999
18
2511
2520
10.1080/07328319908044623

10639752


29.
Volpini
R

Costanzi
S

Lambertucci
C

Taffi
S

Vittori
S

Klotz
KN

Cristalli
G


N
6

3
2B
 ligands
J Med Chem
2002
45
3271
3279
10.1021/jm0109762

12109910


30.
Cristalli
G

Lambertucci
C

Taffi
S

Vittori
S

Volpini
R


2A
 receptor agonists
Curr Top Med Chem
2003
3
387
401
10.2174/1568026033392282

12570757


31.
Volpini
R

Ben
D

Lambertucci
C

Taffi
S

Vittori
S

Klotz
KN

Cristalli
G


N
6

3
 adenosine receptor
J Med Chem
2007
50
1222
1230
10.1021/jm060963u

17309246


32.
Cristalli
G

Cacciari
B

Ben
D

Lambertucci
C

Moro
S

Spalluto
G

Volpini
R


2A
 receptor agonists
Chem Med Chem
2007
2
260
281

17177231


33.
Lean
A

Hancock
AA

Lefkowitz
RJ


Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes
Mol Pharmacol
1982
21
5
16

6982395


34.
Cheng
YC

Prusoff
WH


i
50
) of an enzymatic reaction
Biochem Pharmacol
1973
22
3099
3108
10.1016/0006-2952(73)90196-2

4202581





